India's vaccines quality control procedures under government scrutiny

2 October 2018

Even as three contaminated batches of vaccines have been found with polio type 2 virus in India, a strain that has been eradicated worldwide including India, the Health Ministry has set up a three-member committee to probe if the virus, which was officially eradicated in India in March 2014, has resurrected. The incident has again turned the spotlight on the slipshod pharma quality control procedures in India, reports The Pharma Letter’s India correspondent.

Terming it a public health nightmare of huge proportions, a government official said the occurrence brings to the fore numerous bad manufacturing and risky quality control issues that continue to plague pharmaceutical companies.

The incident is also expected to deal a body blow to India's ability to supply vaccines to global agencies and the World Health Organization (WHO), the official added.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK